Sergio Lupo

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

Pedro Cahn, Juan Sierra Madero, José Ramón Arribas et al. · The Lancet · 2018 · 381 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

A Randomized Clinical Trial Comparing Nelfinavir Or Nevirapine Associated to Zidovudine/Lamivudine in HIV-Infected Naive Patients (The Combine Study)

Daniel Podzamczer, Elena Ferrer, Ezequiel Consiglio et al. · Antiviral Therapy · 2002 · 137 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Efficacy and safety of TMC278 in antiretroviral-naive HIV-1 patients: week 96 results of a phase IIb randomized trial

Anton Pozniak, Javier O Morales-Ramirez, Elly Katabira et al. · AIDS · 2009 · 117 citations

Medicine, Pharmacology, Pharmacotherapy +17

Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial

Yajing Bao, Joy Beeler, Weerawat Manosuthi et al. · The Lancet Infectious Diseases · 2017 · 99 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +10

A comparison of time to exhaustion at [vdot]O2;max in elite cyclists, kayak paddlers, swimmers and runners

Véronique Billat, Marcello Faina, F Sardella et al. · Ergonomics · 1996 · 85 citations

Education, Physiology, Sports Medicine +16